ELLERGEZEN, P. Et Al. 2023. Assessment of α9β1 ıntegrın as a new dıagnostıc and therapeutıc target ın Behcet’s dısease. Clinical and Experimental Medicine , vol.23, no.8 , 5345-5353.

ELLERGEZEN, P., COŞKUN, B. N., Çeçen, G., Bozkurt, Z. Y., AĞCA, H., DALKILIÇ, H. E., ... ÇAVUN, S.(2023). Assessment of α9β1 ıntegrın as a new dıagnostıc and therapeutıc target ın Behcet’s dısease. Clinical and Experimental Medicine , vol.23, no.8, 5345-5353.

ELLERGEZEN, PINAR Et Al. "Assessment of α9β1 ıntegrın as a new dıagnostıc and therapeutıc target ın Behcet’s dısease," Clinical and Experimental Medicine , vol.23, no.8, 5345-5353, 2023

ELLERGEZEN, PINAR Et Al. "Assessment of α9β1 ıntegrın as a new dıagnostıc and therapeutıc target ın Behcet’s dısease." Clinical and Experimental Medicine , vol.23, no.8, pp.5345-5353, 2023

ELLERGEZEN, P. Et Al. (2023) . "Assessment of α9β1 ıntegrın as a new dıagnostıc and therapeutıc target ın Behcet’s dısease." Clinical and Experimental Medicine , vol.23, no.8, pp.5345-5353.

@article{article, author={PINAR ELLERGEZEN Et Al. }, title={Assessment of α9β1 ıntegrın as a new dıagnostıc and therapeutıc target ın Behcet’s dısease}, journal={Clinical and Experimental Medicine}, year=2023, pages={5345-5353} }